You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
McKinsey
Harvard Business School
Colorcon
AstraZeneca

Last Updated: July 6, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR FERRIC CITRATE

» See Plans and Pricing

« Back to Dashboard

505(b)(2) Clinical Trials for ferric citrate

This table shows clinical trials for potential 505(b)(2) applications. See the next table for all clinical trials
Trial Type Trial ID Title Status Sponsor Phase Start Date Summary
New Formulation NCT00967993 Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease Completed Keryx Biopharmaceuticals Phase 2 2010-01-01 The objective of this study is to see if KRX-0502 (ferric citrate) is safe and effective as a dietary phosphate binder in controlling and managing serum phosphorus levels in patients with end-stage renal disease (ESRD).
>Trial Type >Trial ID >Title >Status >Phase >Start Date >Summary

All Clinical Trials for ferric citrate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00648167 A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD) Completed Collaborative Study Group (CSG) Phase 2 2008-03-01 This study is to evaluates the safety and tolerability of Zerenex™ (ferric citrate) as a treatment for hyperphosphatemia in patients with End-Stage Renal Disease.
NCT00648167 A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD) Completed Keryx Biopharmaceuticals Phase 2 2008-03-01 This study is to evaluates the safety and tolerability of Zerenex™ (ferric citrate) as a treatment for hyperphosphatemia in patients with End-Stage Renal Disease.
NCT00967993 Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease Completed Keryx Biopharmaceuticals Phase 2 2010-01-01 The objective of this study is to see if KRX-0502 (ferric citrate) is safe and effective as a dietary phosphate binder in controlling and managing serum phosphorus levels in patients with end-stage renal disease (ESRD).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ferric citrate

Condition Name

Condition Name for ferric citrate
Intervention Trials
Hyperphosphatemia 11
End Stage Renal Disease 10
End-Stage Renal Disease 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for ferric citrate
Intervention Trials
Kidney Diseases 16
Renal Insufficiency, Chronic 15
Kidney Failure, Chronic 15
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for ferric citrate

Trials by Country

Trials by Country for ferric citrate
Location Trials
United States 98
Puerto Rico 4
Israel 3
Taiwan 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for ferric citrate
Location Trials
Texas 8
Michigan 6
California 6
Florida 6
Colorado 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for ferric citrate

Clinical Trial Phase

Clinical Trial Phase for ferric citrate
Clinical Trial Phase Trials
Phase 4 5
Phase 3 8
Phase 2 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for ferric citrate
Clinical Trial Phase Trials
Completed 12
Recruiting 7
Not yet recruiting 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for ferric citrate

Sponsor Name

Sponsor Name for ferric citrate
Sponsor Trials
Keryx Biopharmaceuticals 13
Rockwell Medical Technologies, Inc. 8
Panion & BF Biotech Inc. 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for ferric citrate
Sponsor Trials
Industry 24
Other 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
McKinsey
Medtronic
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.